Navigation Links
Courtney Love Cracks a Joke on Her anorexic Appearance

American rocker Courtney Love looked shockingly thin during her performance at Hiro Ballroom on July 12 in New York City, and even cracked a joke about her emaciated appearance.

The former Hole singer stopped between songs and took a sip from a protein shake, then apologized to the crowd, saying that she "had to take care of my eating disorder."

"I requested Ensure shakes for my anorexia. You're going to have to wait for my eating disorder. Its getting kinda spooky but the free clothes are great, Us Weekly quoted her, as saying.

The 43-year-old singer has also said that she's been trying to quit smoking, but she chain-smoked throughout the concert before the audience that included hotelier Andre Balazs, the Misshapes and Heatherette designers Richie Rich and Traver Rains.

Love debuted new songs from her upcoming Linda Perry-produced album including "How Dirty Girls Get Clean" and the title track, "Nobody's Daughter."

She also belted out a few Hole classics, including "Celebrity Skin" and "Miss World."


'"/>




Page: 1

Related medicine news :

1. Macrobiotic Diet Made Courtney Love Gain 50 Pounds, Not Lose!
2. Maharashtra Cracks Down On Fake Doctors
3. China Cracks the Whip on Pharmaceutical Companies Involved in Bribery
4. Slovenia Cracks Down on Smoking
5. China Cracks the Whip Against Drug Manufacturers Who Fail Quality Norms
6. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
7. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
8. Men Easy To Satisfy Than the Opposite Sex In Terms Of Physical Appearance
9. Appearance Of Facial Scars Improved By Botulinum Toxin

Post Your Comments:
(Date:12/3/2009)... , Leading mental health researchers are warning ...s of climate change will be on mental health, yet ...at the UN climate change conference in Copenhagen ...rom the Institute of Psychiatry (IoP) at King,s Co...y scientists into the potential mental health impa...
(Date:12/3/2009)... 20-year study shows it cut risk factors linked t..., THURSDAY, Dec. 3 (HealthDay News) -- Breast-fe...ficantly lower a woman,s risk of metabolic syndrom...tors -- years later, reports a new study appearing...women who didn,t have pregnancy-related (gestation...
(Date:12/3/2009)... , Cindi Kessock receives... Tulsa, OK (PRWEB) December 2, 2009 -- C...m offering HRMS and ERP applications to businesses...Annual Employee Awards., , ,Each year at their com...evement among their employees. This year, Cindi K...
(Date:12/3/2009)... , Insightra Medical, Inc...announced the launch of its new ventral hernia rep...he standard sublay technique, which completely obv...turing. , (PRWEB) Decembe...based medical device company today announced the l...
(Date:12/3/2009)... , , McALLEN, Texas, Dec. 3 /PRNewswire...SG ), announced today that it has acquired three T...Terrace Rehabilitation & Healthcare Center in ...p; Healthcare in Brownsville; and the 95-bed Veran...he acquisitions were effective December 1, 2009. ,...
Breaking Medicine News(10 mins):Health News:Major impacts of climate change expected on mental health 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 3Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3
...RIE, La., April 15 OrthoSynetics(TM), the largest...dental practices,worldwide, has expanded its sales...ve experience in the orthodontic industry., "Duri...oussos, president and CEO of OrthoSynetics. "The,a...
... the 11 Awards Presented is the Inaugural Randy Pa...ant, EL SEGUNDO, Calif., April 15 The Pancreatic...nnounced today the 2008 Research,Grant Awards reci...six Career Development Awards and one Fellowship A...
...of colon cancer, premature aging poses worries for..., April 15 (HealthDay News) -- Astronauts may be a...ng from the high-energy radiation found in space, ...implications for the long-term space travel necess...
...ts say academics were paid to lend their names to ...s safety , , TUESDAY, April 15 (HealthDay ...ical giant Merck & Co. paid academics to put t...ller. , The company apparently also exaggerated th...
...TINUING SERIES OF PODCASTS FROM PEROT SYSTEMS ON T...HEALTHCARE LOCATION: http://perotsystems.medi... 15 Edition 18, Host: Dr. Kevin Fickenscher - Pe...Orange, California, Perot Systems continues its s...
...LN, Neb., April 15 Mark Hollis, the President of,...edit and debit card,processing in each of MacPract..."his chief concerns in offering this capability we...sident and CEO of Parallel Software stated that "w...
Other Medicine News:Health News:OrthoSynetics(TM) Expands Sales Team; Prepares to Grow 2Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 2Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 3Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 4Health News: Space Radiation a Risk for Astronauts 2Health News:Key Vioxx Research Was Written by Merck, Documents Allege 2Health News:Key Vioxx Research Was Written by Merck, Documents Allege 3Health News:Key Vioxx Research Was Written by Merck, Documents Allege 4Health News:HEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE' 2Health News:HEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE' 3Health News:Parallel Software Announces Integrated Credit Card Processing for MacPractice MD, DDS, DC and 20/20 2
(Date:12/2/2009)...ewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEP... U.S. District Court in Delaware against Teva Phar...ent Nos. 7,132,570 (the ",570 Patent"), 7,297,346 ...") for the Cephalon product NUVIGIL® (armodaf...eriod of marketing exclusivity for NUVIGIL that ex...
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Pharmaceutical Contract Manufacturing -...inker.com/p0164248/Pharmaceutical-Contract-Manufac... pharma industry faces numerous challenges in the ... rising cost of new product development, declining...
(Date:12/2/2009)...ewswire-USNewswire/ -- Jupiter Medical Center ha... tools available into its imaging program, the new... system delivers highly detailed images of the hum...d unique applications, including dual breast scann... with renal dysfunction. This results in shorter ...
Breaking Medicine Technology:Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Jupiter Medical Center Announces New High-Definition MRI System 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 1Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 3Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 4Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 5Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 6Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 7Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 8Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 9Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 10Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 11Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 12Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 13Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 14Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 15State of Oklahoma Offers Invisible Bracelet Health Benefit 57571 1State of Oklahoma Offers Invisible Bracelet Health Benefit 57571 2Immucor to Announce Fiscal First Quarter Financial Results on Thursday October 1 2009 57569 1
...w comparable safety for complex patients treated w...y , , NATICK, Mass., Feb. 18 Boston Scientific C...cation of results from its landmark SYNTAX(TM) tri... of Medicine. In the study, percutaneous coronary...) Paclitaxel-Eluting Coronary Stent System was com...
...TLE, Feb. 18 Cell Therapeutics, Inc.,(Nasdaq and ... efficacy data,from the phase III trial of pixantr... benefit for pixantrone when used as single agent ...essive non-Hodgkin,s lymphoma (NHL). On an,intent-...ved a complete,remission did so during the first 2...
Other Medicine Technology:New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 2New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 3New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 4New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 5Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 2Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 3Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 4
D-DI TEST CARDS
D-DI LATEX
STA LIATEST D-DI
STACLOT LA 10
Medicine Products: